Form 4 for CME CME Group
Accepted 2026-06-29 16:30:05 ET · period of report 2026-06-25 · accession 0001212813-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-29 16:30 | 2026-06-25 | CME | GEPSMAN MARTIN J | Dir | A - Grant | $225.00 | +645 | 25.6K | +3% | +$145.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock Class A | 2026-06-25 | A | A | 645 | $225.00 | 25,644 | D | — | — | (F1) Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions. |